PHARMACY BUYING ASSOCIATION, INC.

Pharmacy Buying Association, Inc. specializes in the manufacturing of pharmaceutical preparations, delivering critical medications and formulations to federal healthcare systems. Their core capabilities center on the production of branded and generic drug products, including tablets, topical agents, and multi-line pharmaceutical formulations, with demonstrated expertise in NDC-compliant manufacturing, batch consistency, and regulatory adherence for controlled substances. They handle complex pharmaceutical compounds such as hydrocortisone, mycophenolate mofetil, zolpidem tartrate, and fluoride toothpaste, indicating proficiency in solid dosage form development, sterile and non-sterile compounding, and cGMP compliance. Their technical focus includes formulation stability, packaging integrity, and supply chain traceability for mission-critical therapeutics. The contractor maintains a consistent and primary relationship with the Department of Veterans Affairs, supplying a wide array of pharmaceuticals to support veteran healthcare delivery across VA medical centers and community-based outpatient clinics. Their work supports VA’s pharmaceutical procurement and distribution network, ensuring uninterrupted access to essential medications for chronic and acute conditions. Their industry focus is narrowly aligned with NAICS 325412—pharmaceutical preparation manufacturing—where they serve as a specialized producer of oral, topical, and other dosage forms for government use. They are positioned as a reliable manufacturer of high-volume, low-margin therapeutics critical to public health infrastructure, with secondary involvement in in-vitro diagnostic substance manufacturing. As a 2L entity based in Kansas City, Missouri, the company operates as a mid-sized manufacturer without federal certifications such as 8(a), HUBZone, or WOSB. Their geographic footprint is centralized, with operations focused on serving federal procurement channels, particularly within the VA system, establishing them as a niche supplier of essential pharmaceuticals to the U.S. government healthcare sector.